Nerve growth factor as a potential treatment in Alzheimer's disease

R. E. Harbaugh

doi:10.1016/0753-3322(89)90108-X

Nerve growth factor as a potential treatment in Alzheimer's disease

R. E. Harbaugh

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

An adequate rationale for considering the use of NGF in the treatment of AD exists. Much basic work needs to be done prior to any clinical trials in order to design an ethically and scientifically sound study. The potential use of NGF in patients with AD is a very exciting possibility; enthusiasm should not, however, lead to poorly designed premature clinical trials which are unlikely to provide definitive answers as to the effectiveness of such treatment.

Original language	English (US)
Pages (from-to)	483-485
Number of pages	3
Journal	Biomedicine and Pharmacotherapy
Volume	43
Issue number	7
DOIs	https://doi.org/10.1016/0753-3322(89)90108-X
State	Published - 1989

All Science Journal Classification (ASJC) codes

Pharmacology

Access to Document

10.1016/0753-3322(89)90108-X

Cite this

@article{5a5420b4df0949e6b98be0ec5c9279db,

title = "Nerve growth factor as a potential treatment in Alzheimer's disease",

abstract = "An adequate rationale for considering the use of NGF in the treatment of AD exists. Much basic work needs to be done prior to any clinical trials in order to design an ethically and scientifically sound study. The potential use of NGF in patients with AD is a very exciting possibility; enthusiasm should not, however, lead to poorly designed premature clinical trials which are unlikely to provide definitive answers as to the effectiveness of such treatment.",

author = "Harbaugh, {R. E.}",

year = "1989",

doi = "10.1016/0753-3322(89)90108-X",

language = "English (US)",

volume = "43",

pages = "483--485",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson s.r.l.",

number = "7",

}

TY - JOUR

T1 - Nerve growth factor as a potential treatment in Alzheimer's disease

AU - Harbaugh, R. E.

PY - 1989

Y1 - 1989

N2 - An adequate rationale for considering the use of NGF in the treatment of AD exists. Much basic work needs to be done prior to any clinical trials in order to design an ethically and scientifically sound study. The potential use of NGF in patients with AD is a very exciting possibility; enthusiasm should not, however, lead to poorly designed premature clinical trials which are unlikely to provide definitive answers as to the effectiveness of such treatment.

AB - An adequate rationale for considering the use of NGF in the treatment of AD exists. Much basic work needs to be done prior to any clinical trials in order to design an ethically and scientifically sound study. The potential use of NGF in patients with AD is a very exciting possibility; enthusiasm should not, however, lead to poorly designed premature clinical trials which are unlikely to provide definitive answers as to the effectiveness of such treatment.

UR - http://www.scopus.com/inward/record.url?scp=0024469207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024469207&partnerID=8YFLogxK

U2 - 10.1016/0753-3322(89)90108-X

DO - 10.1016/0753-3322(89)90108-X

M3 - Article

C2 - 2684291

AN - SCOPUS:0024469207

SN - 0753-3322

VL - 43

SP - 483

EP - 485

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

IS - 7

ER -

Nerve growth factor as a potential treatment in Alzheimer's disease

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this